<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<!-- saved from url=(0068)https://era.bfs.de/studies_description_from_db.php?LabId=2&StudyId=6 -->
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" slick-uniqueid="3"><head><meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">


	
	<meta name="author" content="Michael Gruenberger mg287@cam.ac.uk">
	<meta name="keywords" content="european, radiation, database">
	<meta name="description" content="ERA: European Radiobiological Archives">
	<meta name="robots" content="all">
	<title>ERA: European Radiobiological Archives</title>

<script language="javascript" src="./2-6_files/alttxt.js"></script>
	
	<style type="text/css" title="currentStyle" media="screen">@import "index_wide.css";</style>
	<link rel="Shortcut Icon" type="image/x-icon" href="https://era.bfs.de/favicon.ico">	
<script type="text/javascript" src="chrome-extension://bfbmjmiodbnnpllbbbfblcplfjjepjdn/js/injected.js"></script><style type="text/css"></style><style id="bitmark_stylesheet" type="text/css"></style></head><body id="css-zen-garden" text="#000000" link="#0000ff" vlink="#551a8b" alink="#ff0000" bgcolor="#c0c0c0" style="">

<div id="container">
	<div id="intro">
		<div id="quickSummary">
		<p class="p2">
		  <a href="https://era.bfs.de/index.php" style="background: #1680c4 url(images/nav_home.gif) top left no-repeat;position:absolute;left:0px;top:-60px;border:0px;padding: 40px 40px 0 30px; width: 141px;
"></a>
		</p><div class="p3">		  <a style="padding-bottom:2px;margin-bottom:2px;">
		    <form action="https://era.bfs.de/studies_search.php" method="GET">
		    <input type="hidden" name="stage" value="3">
		    <input type="text" name="query" style="width:100px; position:relative;left:-20px;" onmouseover="writetxt(&#39;Searches study name and description. Combine multiple terms to run an AND query or specify an OR query, e.g. tumor OR tumour&#39;)" onmouseout="writetxt(0)">
		    <input type="submit" value="Search" style="position:relative;left:100px;top:-20px;">
		    </form>
		  </a>
		  <a style="padding:2px;" href="https://era.bfs.de/studies_search.php" onmouseover="writetxt(&#39;Searches study, group and individual organism data by pathology, anatomy, exposure etc.&#39;)" onmouseout="writetxt(0)">Advanced Search</a><br><br>
		  <a style="padding:2px;" href="https://era.bfs.de/studies_search.php?stage=3&type=browse" onmouseover="writetxt(&#39;List all studies sorted by lab.&#39;)" onmouseout="writetxt(0)">Browse Studies</a>

		<br><br><br><a href="https://era.bfs.de/contacts.php?t=feedback" onmouseover="writetxt(&#39;Comments, suggestions, improvements? Click here to send your feedback!&#39;)" onmouseout="writetxt(0)">Feedback</a>		</div>
		<p></p>
		</div>
	<div id="preamble">
			<h3><span>ERA: Studies Description</span></h3>
			
			<p style="font-size:.5em;font-weight:bold;width:300px;border:1px;background-color:#DFDBD3;float:right">Please note: The data below has been compiled for the original ERA CD and for printing the ERA book. The data in the database might have changed since then. Please follow the link at the bottom at the page to view the 'live' data.</p>
			<p class="p1"><span>
			<synopsis1>

<title></title>



</synopsis1></span></p><h3>02.06 Lung Tumors in Rats After Inhalation of Radon and Treatment with Different Cofactors</h3>

<p><strong>Institution: CEA, DSV-DPTE (IPSN) Fontenay-aux Roses and COGEMA, France</strong></p>

<p><strong>Scientists:</strong> M. Morin; R. Masse;&nbsp; J. Chameaud; J. Lafuma;</p>

<p><strong>Purpose:</strong> To determine the risks of lung tumors after inhalation of radon in combination with treatment with various cofactors.</p>

<p><strong>Status:</strong> 1973- ongoing; data in ERAD</p>

<p><strong>Treatment:</strong> Inhalation of radon (0.1-0.3 &#956;m AMAD 6.2% unattached), treatment with radiation, radionuclides or different cofactors, for details see individual
experiments below.</p>

<p><strong>Dosimetry:</strong> Activity inhaled (dose from daughter products deposited 2-3 mGy/WLM), for Triton see 02.14</p>

<p><strong>Endpoints:</strong> Life-span study (spontaneous death) with macroscopic/microscopic pathology unless otherwise stated below</p>

<p><strong>Animal:</strong> Male Sprague-Dawley SPF rats of different ages as indicated below</p>

<p><strong>Results:</strong> Several pharmaceutical active agents were given together with radon exposure to test whether, on the one hand, certain of these substances (eg
cyclophosphamide, bleomycine, methotrexate) would reduce the incidence of cancer, or, on the other hand, whether such substances when used for different
therapeutic purposes (eg rifampicine, BCG, isoniazide, endoxan, largactil, phenobarbitol) could act as cofactors for radon-induced cancer. None of the
substances had any positive or negative effect on the rate of incidence of radon-induced lung cancer. Alcohol also had no effect whatsoever.</p>

<p><strong>References (for 02.02-02.06):</strong></p>

<p>Chameaud, J., R. Perraud, J. Lafuma, A. Collet and H. Daniel-Moussard. Étude expérimentale chez le rat de l'influence du radon sur le poumon normal et
empoussiéré. <em>Arch. Maladies Profess. Méd. de Travail</em> <strong>29</strong>:29-40, 1968.</p>

<p>Perraud, R., J. Chameaud, R. Masse and J. Lafuma. Cancers pulmonaires chez le rat après inhalation de radon associé à des poussières non radioactives.
<em>Comptes Rendus Acad. Sc., D</em><strong> 270</strong>:2594-2595, 1970.</p>

<p>Chameaud, J., R. Perraud and J. Lafuma. Cancers du poumon expérimentaux provoqués chez le rat par des inhalations de radon. <em>Comptes Rendus Acad. Sc., D</em>
<strong>273</strong>:2388-2389, 1971.</p>

<p>Perraud, R. and J. Chameaud. Cancer broncho-pulmonaire expérimental du rat par inhalation de radon; comparaison avec les aspects histologiques des cancers
humains<em>. J. Fr. Chirurg. Thorac.</em>, <strong>26</strong>:25-41, 1972.</p>

<p>Chameaud, J., R. Perraud, J. Lafuma and J. Pradel. Lesions and lung cancers induced in rats by inhaled radon-222 at various equilibriums with radon daughters,
pp. 411-421. <em>In</em> E. Karbe and J.F. Park [eds.], <em>Experimental Lung Cancer</em>, Vol<strong>. 1</strong>. Springer Verlag, New York, 1974.</p>

<p>Chameaud, J., R. Perraud, R. Masse, J.C. Nénot and J. Lafuma. Cancers du poumon provoqués chez le rat par le radon et ses descendants à diverses
concentrations, pp. 223-228. <em>In</em> IAEA-Sm-202/404 [ed.], <em>Biological and Environmental Effects of Low Level Radiation</em>, Vol. II. IAEA, Vienna, 1976.</p>

<p>Chameaud, J., R. Perraud, J. Chrétien, R. Masse and J. Lafuma. Étude expérimentale de l'action de la fumée de cigarettes et du dépôt actif du radon-222, pp.
429-436. <em>In</em> IAEA-SM 224-805 [ed.],<em> Late Biological Effects of Ionizing Radiation</em>, Vol. II. IAEA, Vienna, 1978. Chameaud, J., R. Perraud, J. Chrétien, R.
Masse and J. Lafuma. Combined effects of inhalation of radon daughter products and tobaccor smoke, pp. 551-557. <em>In</em> C.L. Sanders, F.R. Cross, G.E. Dagle and
J.A. Mahaffey [eds.], <em>Pulmonary Toxicology of Respirable Particles</em>. US DOE Technical Information Center, Washington, Annual Hanford Symposium, 1979.</p>

<p>Métivier, H., R. Masse, I. L'Huillier and J. Lafuma. Étude de l'action combiné de l'oxyde de plutonium inhalé et de deux cancérogènes chimiques de
l'environment, pp. 93-104. <em>In</em> IAEA-SM-237/33 [ed.], <em>Biological Implications of Radionuclides Released from Nuclear Industries</em>, Vol. II. IAEA, Vienna,
1979.</p>

<p>Chameaud, J., R. Perraud, R. Masse and J. Lafuma. Contribution of animal experimentation to the interpretation of epidemiological data, pp. 222-227. <em>In</em> Proc.
Intern. Conference Oct 4-0 1981 Golden CO: <em>Radiation Hazards in Mining: Control, Measurement and Medical Aspects</em>. Kingsport Press, Kingsport TE, 1981.</p>

<p>Chameaud, J., R. Perraud, J. Chrétien, R. Masse and J. Lafuma. Lung carcinogenesis during <em>in vivo</em> cigarette smoking and radon daughter exposure in rats.
<em>Recent Results Cancer Res</em><strong>. 82</strong>:11-20, 1982.</p>

<p>Chameaud, J., R. Perraud, J. Lafuma and R. Masse. Cancers induced by Rn-222 in rats, pp. 198-202. <em>In</em> G.F. Clemente, A.V. Nero, F. Steinhäusler and M.E.
Wrenn [eds.],<em> The Assessment of Radon and Daughter Exposure and Related Biological Effects</em> ISBN 0-904636. RD Press Univ. of Utah, Salt Lake City, 1982.</p>

<p>Chmelevsky, D., A. Kellerer, J. Lafuma and J. Chameaud. Maximum likelihood estimation of the prevalence of nonlethal neoplasms - an application to radon
daughter inhalation studies. <em>Radiat. Res.</em> <strong>91:</strong>589-614, 1982.</p>

<p>Lafuma, J. Les effets cancérigènes du radon 222 et de ses produits de filiations. Données épidémiologiques et expérimentales, pp. 242-252. <em>In</em> P. Galle [ed.],<em>
Toxiques Nucléaires.</em> Mason, Paris, 1982.</p>

<p>Bignon, J., G. Monchaux, J. Chameaud, M.C. Jaurand, J. Lafuma and R. Masse. Incidence of various types of thoracic malignancy induced in rats by intrapleural
injection of various metal dusts after inhalation of <sup>222</sup>Rn.<em> Carcinogenesis </em><strong>4</strong>:621-628, 1983.</p>

<p>Chameaud, J., R. Perraud, R. Masse and J. Lafuma. Étude expérimentale de l'action cancérigène de radon-222. Comparaison avec les études épidémiologiques.
<em>Radioprotection </em><strong>18:</strong>95-105, 1983.</p>

<p>Chameaud, J., R. Masse and J. Lafuma. Influence of radon daughter exposure at low doses on occurrence of lung cancer in rats. <em>Rad. Protection Dosimetry</em>
<strong>7</strong>:385-388, 1984.</p>

<p>Chameaud, J., R. Masse, M. Morin and J. Lafuma. Lung cancer induction by radon daughters in rats, pp. 1350-1353. <em>In</em> <em>Occupational Safety in Mining</em>.
Toronto, 1984.</p>

<p>Chameaud, J., R. Masse and J. Lafuma. The etiology of lung cancer; epidemiology and animal experimentation complementary, p. 12 pages. <em>In</em> Intern.Acad.
Chest Physicians and Surgeons [ed.], <em>Symposium on future tuberculosis control</em>. Republic of China, Taiwan, 1986.</p>

<p>IARC (Ed.). Man-made Mineral Fibres and Radon. 43 vols. IARC, Lyon, Series Ed: IARC Working Group 16-23 June 1987. Monographs on the <em>Evaluation of
Carcinogenic Risks to Humans.,</em> 1987.</p>

<p>Masse, R. and J. Chameaud. Experimentation animale, pp. 71-79. <em>In</em> Exposition au Radon dans les habitations; aspects techniques et sanitaires. SHFR, Paris,
1989.</p>

<p>Masse, R. and F.T. Cross. Risk considerations related to lung modeling. <em>Health Phys.</em> <strong>57</strong> Suppl.1:283-289, 1989.</p>

<p>Masse, R., J. Lafuma and J. Chameaud. Cancers des voies aériennes induits chez le rat par la fumée de tabac. <em>Path.Biol.</em> <strong>37:</strong>1047-1049, 1989.</p>

<p>Monchaux, G., J. Chameaud, J.P. Morlier, X. Janson, M. Morin and J. Bignon. Translocation of subcutaneously injected chrysotile fibres: potential
cocarcinogenic effect on lung cancer induced in rats by inhalation of radon and its daughters, pp. 161-166. <em>In</em> J. Bignon, J. Peto and R. Saracci [eds.],<em>
Non-occupational Exposure to Mineral Fibers</em>. IARC, Lyon, IARC Scientific Publication, 1989.</p>

<p>Mura, P., J.P. Morlier, M. Barriere, P. Bredon, Y. Papet and J. Chameaud. Increased biopterin production in rats with tumors induced by radon inhalation and
benzonaphthoflavone administration.<em> Cancer Letters</em> <strong>54:</strong>57-60, 1990.</p>

<p>Masse, R., M. Morin, J. Chameaud and J. Lafuma. Animals exposed to radon, pp. 603-610. <em>In</em> A. Janssens, W. Lowder, M. Olast, J. Sinnaeve and F.
Steinhäusler [eds.], The Natural Radiation Environment, 5th International Symposim on the Natural Radiation Environment. <em>Radiation Protection Dosimetry </em><strong>45</strong>
Suppl. Brussels Luxembourg, 1992.</p>

<p>Morlier, J.P., M. Morin, J. Chameaud, R. Masse, S. Bottard and J. Lafuma. Importance du rôle du débit de dose sur l'apparition des cancers chez le rat après
inhalation de radon. <em>Comptes Rendus Acad. Sc</em>. <strong>315:</strong>463-466, 1992.</p>

<p>Bisson, M., C.G. Collier, J.L. Poncy, A. Taya, J.P. Morlier, J. Strong, S. Baker, G. Monchaux and P. Fritsch. Biological dosimetry in different compartments of
the respiratory tract after inhalation of radon and its daughters. <em>Rad. Protection Dosimetry</em> <strong>56</strong>:89-92, 1994.</p>

<p>Bisson, M., J.P. Morlier, P. Fritsch, H. Richard, S. Altmeyer and G. Monchaux. Biological dosimetry in alveolar tissue and early<sup> 214</sup>Pb retention in the respiratory
tract of the rat after radon exposure under different physical conditions. <em>Ann. Assoc. Belge Radioprot</em>.<strong> 19</strong>:61-68, 1994.</p>

<p>Douriez, E., P. Kermanac'h, P. Fritsch, M. Bisson, J.P. Morlier, G. Monchaux, M. Morin and P. Laurent. Cocarcinogenic effect of cytochrome P-450 1A1
inducers for epidermoid lung tumor induction in rats previously exposed to radon. <em>Rad. Protection Dosimetry</em> <strong>56</strong>:105-108, 1994.</p>

<p>Monchaux, G and R. Masse. Radon: occupational or domestic carcinogen? <em>Rad. Protection Dosimetry</em> <strong>56</strong>:81-88, 1994.</p>

<p>Monchaux, G., J.R. Morlier, M. Morin and R. Masse. Induction of lung cancer by exposure to radon and radon daughters in rats.<em> Ann. Assoc. Belge Radioprot</em>.
<strong>19:</strong>27-60, 1994.</p>

<p>Morlier, J.P., M. Morin, G. Monchaux, P. Fritsch, J.F. Pineau, J. Chameaud, J. Lafuma and R. Masse. Lung cancer incidence after exposure of rats to low doses
of radon: influence of dose rate.<em> Rad. Protection Dosimetry </em><strong>56</strong>:93-97, 
1994.</p>

<p align="CENTER"><strong>Experimental Groups:</strong></p>

<p align="CENTER"><strong>Study 02.06: Lung Tumors in Rats After Inhalation of Radon and Treatment with Different Cofactors </strong><br>
<br>

</p><table align="CENTER" border="1" cellpadding="1" cellspacing="1">
<tbody><tr valign="BOTTOM"><td align="CENTER"><strong>Group Id</strong></td>
<td><strong>Expos. WLM (Conc.WL)</strong></td>
<td><strong>Age months (Exp.mo)</strong></td>
<td><strong>Treatment</strong></td>
<td><strong>No rats</strong></td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">1</font></strong></td>
<td>5600 (4800)</td>
<td>2.5 (3)</td>
<td>Fe-59 IT</td>
<td>10</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">2</font></strong></td>
<td>5600 (4800)</td>
<td>2.5 (3)</td>
<td><sup>144</sup>Ce IM</td>
<td>10</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">3</font></strong></td>
<td>40 (120)</td>
<td>2.5 (1)</td>
<td>Neutrons Triton 3.05 Gy +250 d</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">4</font></strong></td>
<td>200 (800)</td>
<td>2.5 (0.5)</td>
<td>Neutrons Triton 2.14 Gy +245 d</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">5</font></strong></td>
<td>2240 (1200)</td>
<td>2.5 (2.5)</td>
<td>Butter yellow OR +190 d cont.</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">6</font></strong></td>
<td>0</td>
<td>5 (3)</td>
<td>Methylcholanthrene once/w IP 25mg/kg +365 (465) d </td>
<td>12</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">7</font></strong></td>
<td>2100 (1050)</td>
<td>12 (3)</td>
<td>Methylcholanthrene once/w IP 25mg/kg +365 d</td>
<td>6</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">8</font></strong></td>
<td>2100 (3600)</td>
<td>2.5 (1)</td>
<td>5-Fluorouracil once/w +1d* </td>
<td>30</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">9</font></strong></td>
<td>2100 (3600)</td>
<td>2.5 (1)</td>
<td>Endoxan 50 mg/kg once/w +1d* </td>
<td>30</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">10</font></strong></td>
<td>2100 (1050</td>
<td>5 (2)</td>
<td>Endoxan 50 mg/kg once/w +1d*</td>
<td>30</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">11</font></strong></td>
<td>2100 (3600)</td>
<td>2.5 (1)</td>
<td>Bleomycine 10 &#956;g once/w +450d*</td>
<td>30</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">12</font></strong></td>
<td>1960 (1050)</td>
<td>2.5 (2)</td>
<td>Largactil oral 400 mg/l +113 d for 84 d </td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">13</font></strong></td>
<td>1960 (1050)</td>
<td>2.5 (2)</td>
<td>Phenothiazine IM 40 mg/kg +112d 12x7 d</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">14</font></strong></td>
<td>2240 (1200)</td>
<td>2.5 (2.5)</td>
<td>Promethazin OR +190 d</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">15</font></strong></td>
<td>2100 (1050)</td>
<td>2.5 (2)</td>
<td>Phenobarbital IP +365 d</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">16</font></strong></td>
<td>2240 (1200)</td>
<td>2.5 (2.5)</td>
<td>Phenobarbital IP+OR 80mg/kg +190d 12x7d (2)+ cont.</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">17</font></strong></td>
<td>1000 (1000)</td>
<td>2.5 (1.5)</td>
<td>INH IP 35 mg/kg+169 d 12x7 d</td>
<td>8</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">18</font></strong></td>
<td>1960 (1050)</td>
<td>2.5 (2)</td>
<td>INH IP 35 mg/kg +118 d 12x7 d (x2)</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">19</font></strong></td>
<td>1000 (1000)</td>
<td>2.5 (1.5)</td>
<td>Rifampicine IP 50 mg/kg +1 d 2x /w</td>
<td>8</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">20</font></strong></td>
<td>2240 (1200)</td>
<td>2.5 (2.5)</td>
<td>Rifampicine IP 50 mg/kg +190d 12x7d(2)</td>
<td>16</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">21</font></strong></td>
<td>1000 (1000)</td>
<td>2.5 (1.5)</td>
<td>0.6 mg/kg acetylaminofluorene 12 w +170d</td>
<td>8</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">22</font></strong></td>
<td>1000 (1000)</td>
<td>2.5 (1.5)</td>
<td>Pentamethylquercetin +171d</td>
<td>8</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">23</font></strong></td>
<td>2800 (1050)</td>
<td>2.5 (3)</td>
<td>BCG +1 d {therapeutic human dose scaled to rat}</td>
<td>20</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">24</font></strong></td>
<td>2100 (1050)</td>
<td>5 (2)</td>
<td>BCG +450 d {therapeutic human dose scaled to rat}</td>
<td>30</td></tr>
<tr valign="TOP"><td align="CENTER"><strong><font color="#005000">25</font></strong></td>
<td>1000 (1000)</td>
<td>2.5 (1.5)</td>
<td>Wine ad lib. +67 d cont.</td>
<td>8</td></tr>
<tr valign="TOP"><td colspan="4" align="CENTER"><b>Total</b></td>
<td><b>408</b></td></tr></tbody></table>

<p>Three doses following the European standard treatment protocol scaled for rats<br>
<strong>Abbreviations</strong>: +### d: application ### days after (-### d before) radon exposure; *x# d #: * applications over # days. IM intramuscular, IP intraperitoneal, IT
intratracheal, OR oral <br>
INH Isonicotine acid hydrazide, BCG extract Bac. Calmette-Guerin</p>


			<a href="https://era.bfs.de/studies_details.php?LabId=2&StudyId=6">Please click here to view the 'live' data in ERA</a><br> 
			<p></p>
			
		</div>
	</div>

	
	<div id="supportingText">
		<div id="explanation">
			<h3><span></span></h3>
			<p class="p1"><span><!--More text here --></span></p>
		</div>

		<div id="footer">
			A co-operation between the <a href="http://www.bfs.de/">Federal Office for Radiation Protection, Germany</a> and the <a href="http://www.cam.ac.uk/">University of Cambridge, England</a>. Funded by the EU's EURATOM FP6 framework programme. © BfS
		</div>

	</div>
	<!--	<div id="linkList">
		<div id="linkList2">
			<div id="lselect">
				<h3 class="select"><span>About ERA:</span></h3>
				<ul>
					<li><a href="contacts.php">Contacts</a></li>
					<li><a href="advisoryboard.php">Advisory Board</a></li>
					<li><a href="wiki.php">News</a></li>
					<li><a href="toc.php">Terms and Conditions</a></li>

				</ul>
			</div>

			<div id="larchives">
				<h3 class="archives"><span>Resources:</span></h3>
				<ul>
					<li><a href="publications.php">ERA Publications</a></li>
					<li><a href="http://www.pathbase.net/zoomify/era_index.php">High resolution images</a></li>
					<li><a href="statistics.php">ERA Statistics</a></li>
					<li><a href="webservices.php">Webservices</a></li>
				</ul>
			</div>
			<div id="lresources">
				<h3 class="resources"><span>News from ERRS:</span></h3>
				<ul>
					<li>no news from errs at the moment.</li>					<li><a href="http://www.euradnews.org" title="The latest from www.euradnews.org">More news from ERRS</a></li>
					

				</ul>
			</div>
		</div>
	</div>
	-->

</div>
<div id="navtxt" class="navtext" style="position: absolute; top: -100px; left: 0px; visibility: hidden; padding: 4px;"></div>



</body></html>